Atai Life Sciences NV Sustainability Reports
A clinical-stage biotechnology company that develops treatments for mental health disorders. It focuses on therapies based on psychedelics, entactogens, and related compounds.
Sector: Manufacturing
Country: Netherlands
Exchange: Nasdaq
LEI: 391200Z8UWPJSNBNCA11
3 reports from 2021 to 2023
Company Profile
A clinical-stage biotechnology company that develops treatments for mental health disorders. It focuses on therapies based on psychedelics, entactogens, and related compounds.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
